These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10196295)

  • 1. Gene therapy vectors based on adeno-associated virus type 1.
    Xiao W; Chirmule N; Berta SC; McCullough B; Gao G; Wilson JM
    J Virol; 1999 May; 73(5):3994-4003. PubMed ID: 10196295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.
    Hewitt FC; Li C; Gray SJ; Cockrell S; Washburn M; Samulski RJ
    J Virol; 2009 Apr; 83(8):3919-29. PubMed ID: 19211760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses.
    Mendoza SD; El-Shamayleh Y; Horwitz GD
    J Neurophysiol; 2017 May; 117(5):2004-2013. PubMed ID: 28202570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.
    Wang L; Bell P; Somanathan S; Wang Q; He Z; Yu H; McMenamin D; Goode T; Calcedo R; Wilson JM
    Mol Ther; 2015 Dec; 23(12):1877-87. PubMed ID: 26412589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the potential for AAV vector genotoxicity in a murine model.
    Li H; Malani N; Hamilton SR; Schlachterman A; Bussadori G; Edmonson SE; Shah R; Arruda VR; Mingozzi F; Wright JF; Bushman FD; High KA
    Blood; 2011 Mar; 117(12):3311-9. PubMed ID: 21106988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Fc Receptor Inhibition Enables Adeno-Associated Virus Gene Therapy Despite Pre-Existing Humoral Immunity.
    Horiuchi M; Hinderer CJ; Shankle HN; Hayashi PM; Chichester JA; Kissel C; Bell P; Dyer C; Wilson JM
    Hum Gene Ther; 2023 Oct; 34(19-20):1022-1032. PubMed ID: 36719773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preexisting Neutralizing Antibodies against Different Adeno-Associated Virus Serotypes in Humans and Large Animal Models for Gene Therapy.
    Ail D; Dalkara D
    Adv Exp Med Biol; 2023; 1415():117-123. PubMed ID: 37440023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumventing B Cell Responses to Allow for Redosing of Adeno-Associated Virus Vectors.
    Ertl HCJ
    Hum Gene Ther; 2024 Jul; 35(13-14):416-424. PubMed ID: 37861281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T Cells.
    De BP; Cram S; Lee H; Rosenberg JB; Sondhi D; Crystal RG; Kaminsky SM
    Hum Gene Ther; 2023 Aug; 34(15-16):697-704. PubMed ID: 37171121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector.
    Wang L; Wang H; Bell P; McMenamin D; Wilson JM
    Hum Gene Ther; 2012 May; 23(5):533-9. PubMed ID: 22098408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient removal of antibodies to adeno-associated viruses by immunoadsorption.
    Boedecker-Lips S; Judel A; Holtz S; Mayer M; Klimpke P; Kraus D; Schreiner T; Gerstmayer B; Eulitz K; Mayer MC; Weinmann-Menke J
    J Clin Apher; 2023 Oct; 38(5):590-601. PubMed ID: 37415533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates.
    Li H; Lasaro MO; Jia B; Lin SW; Haut LH; High KA; Ertl HC
    Mol Ther; 2011 Nov; 19(11):2021-30. PubMed ID: 21587208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme.
    Elmore ZC; Oh DK; Simon KE; Fanous MM; Asokan A
    JCI Insight; 2020 Sep; 5(19):. PubMed ID: 32941184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goats with low levels of AAV antibody may serve as candidates for large animal gene therapy.
    Pan H; Liu YF; Luo Y; Chen L; Shen B; Song S; Liu M; Wang Z; Wu W; Li M; Zhang Y
    Exp Eye Res; 2023 Aug; 233():109514. PubMed ID: 37207869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing.
    Gonzalez TJ; Simon KE; Blondel LO; Fanous MM; Roger AL; Maysonet MS; Devlin GW; Smith TJ; Oh DK; Havlik LP; Castellanos Rivera RM; Piedrahita JA; ElMallah MK; Gersbach CA; Asokan A
    Nat Commun; 2022 Oct; 13(1):5947. PubMed ID: 36210364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation.
    Cabanes-Creus M; Liao SHY; Gale Navarro R; Knight M; Nazareth D; Lau NS; Ly M; Zhu E; Roca-Pinilla R; Bugallo Delgado R; Vicente AF; Baltazar G; Westhaus A; Merjane J; Crawford M; McCaughan GW; Unzu C; González-Aseguinolaza G; Alexander IE; Pulitano C; Lisowski L
    Nat Commun; 2024 Mar; 15(1):1876. PubMed ID: 38485924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Anti-AAV Antibody Depletion by Hemapheresis and Immunoadsorption.
    Orlowski A; Weber T
    Methods Mol Biol; 2022; 2573():235-248. PubMed ID: 36040599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery.
    Hudry E; Aihara F; Meseck E; Mansfield K; McElroy C; Chand D; Tukov FF; Penraat K
    Mol Ther; 2023 Oct; 31(10):2999-3014. PubMed ID: 37515322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer.
    Wang D; Zhong L; Li M; Li J; Tran K; Ren L; He R; Xie J; Moser RP; Fraser C; Kuchel T; Sena-Esteves M; Flotte TR; Aronin N; Gao G
    Mol Ther Methods Clin Dev; 2018 Dec; 11():65-72. PubMed ID: 30397628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome.
    Ding WY; Kuzmuk V; Hunter S; Lay A; Hayes B; Beesley M; Rollason R; Hurcombe JA; Barrington F; Masson C; Cathery W; May C; Tuffin J; Roberts T; Mollet G; Chu CJ; McIntosh J; Coward RJ; Antignac C; Nathwani A; Welsh GI; Saleem MA
    Sci Transl Med; 2023 Aug; 15(708):eabc8226. PubMed ID: 37556557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.